A new study published in the European Journal of Medical Research revealed that dapagliflozin, a sodium-glucose ...

There is lower risk for recurrent HF hospitalization in older patients that receive SGLT2is following acute decompensated heart failure.

US-based Cardurion Pharmaceuticals has completed enrolment in two multi-centre, global Phase II CYCLE trials of the ...

Left bundle branch block may serve as an important indicator for asymptomatic individuals predisposed to heart failure.

TX45 PH-ILD Phase 2 clinical trial is planned to initiate in 2026 to evaluate TX45’s safety and hemodynamic effects in subjects with Pulmonary Hypertension associated with Interstitial Lung Disease ...

A post hoc analysis of the SUMMIT trial, published in JACC, reveals that baseline body mass index (BMI) and fat distribution ...

Early symptoms like fatigue, breathlessness, swelling mimic common heart issues, causing cardiac amyloidosis to go undetected ...

Pharmacotherapy is an effective, evidence-based treatment for people living with obesity, as part of a long-term, ...

Key Points GAAP revenue surged to $66.8 million in Q2 2025, driven by recognition of one-time license and milestone payments, exceeding analyst estimates by 3,065.9% (GAAP). GAAP loss per share ...

Pharmacotherapy can help people living with obesity improve overall health, not just lose weight," says Dr. Sue D. Pedersen, MD, endocrinologist and ...

An anti-hazing network honors a UVA leader, the American Heart Association lauds UVA Health for heart and stroke care, and ...

Source: Analyst estimates for the quarter provided by FactSet.